Latest

Riskfocus Webinar Part 4

There is no end of research extoling the grim realities or lamenting the high costs and negative impacts of Trade and Transaction Reporting, unfortunately, it’s not going away. We thought

Riskfocus Webinar Part 2

There is no end of research extoling the grim realities or lamenting the high costs and negative impacts of Trade and Transaction Reporting, unfortunately, it’s not going away. We thought

The Biggest Opportunity From MiFID II
EU moves to recognise equivalence of US, Swiss stock exchanges before MIFID 2
MiFID II demands & how research is priced – John Dwyer from Celent/Oliver Wyman
Citadel Securities’ Paul Hamill on MiFID, Regulations